Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

FRX

Ferrex (FRX)

Ferrex
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:FRX
DateTimeSourceHeadlineSymbolCompany
07/19/20226:30AMRNS Non-RegulatoryKeras Resources PLC Update regarding Investor Presentation and GMLSE:FRXFerrex
06/22/20229:20AMRNS Non-RegulatoryKeras Resources PLC New Date - Shareholder/Investor PresentationLSE:FRXFerrex
06/09/20221:03AMRNS Non-RegulatoryKeras Resources PLC Shareholder/Investor Meeting and PresentationLSE:FRXFerrex
06/24/20218:36AMRNS Non-RegulatoryKeras Resources PLC Updated Corporate PresentationLSE:FRXFerrex
10/30/20192:00AMRNS Non-RegulatoryKeras Resources PLC Joint Investor Event - Further DetailsLSE:FRXFerrex
09/14/20186:00AMRNS Non-RegulatoryKeras Resources PLC Investor EventLSE:FRXFerrex
11/23/20179:55AMRNS Non-RegulatoryKeras Resources PLC New Company PresentationLSE:FRXFerrex
11/16/20173:47AMRNS Non-RegulatoryKeras Resources PLC Pilbara Gold Presentation-London 23 November 2017LSE:FRXFerrex
08/01/20171:02AMRNS Non-RegulatoryKeras Resources PLC Brandon Hill ResearchLSE:FRXFerrex
04/12/20166:20AMRNS Non-RegulatoryKeras Resources PLC New Corporate PresentationLSE:FRXFerrex
03/18/20162:00AMRNS Non-RegulatoryKeras Resources PLC Corporate PresentationLSE:FRXFerrex
10/29/20094:54AMDow Jones NewsRichter To Start Late Stage Tests On Key Schizophrenia DrugTSX:FRXForest Laboratories Inc.
10/29/20093:47AMDow Jones NewsHungary Richter, US Forest Announce Positive Drug TestsTSX:FRXForest Laboratories Inc.
08/27/20095:31PMPR Newswire (US)Four Studies Published in The Lancet Show roflumilast (Daxas(R)), a New Oral Approach to COPD, Improves Lung Function and ReduceTSX:FRX
08/19/20098:50AMDow Jones News2nd UPDATE: Glenmark, Forest Say Their Drug Failed In TrialsTSX:FRXForest Laboratories Inc.
08/19/20092:53AMDow Jones NewsUPDATE: Glenmark, Forest Say Oglemilast Failed In Key StudyTSX:FRXForest Laboratories Inc.
08/12/20093:32AMDow Jones NewsAstraZeneca, Forest Labs Ink Ceftaroline DealTSX:FRXForest Laboratories Inc.
08/10/20096:00AMPR Newswire (US)Nycomed and Forest Laboratories to Collaborate on US Commercialisation of Daxas(R) in COPDTSX:FRX
07/21/20098:08AMDow Jones NewsForest Labs 1Q Net Up 8.2% As Namenda Sales JumpTSX:FRXForest Laboratories Inc.
06/22/20098:20AMPR Newswire (US)Beacon Equity Research on Stocks to Watch: Forest Labs, Harris, Philip Morris, IAMGOLD, Steel Dynamics and WyndhamTSX:FRX
06/19/20091:40PMDow Jones NewsForest Labs Reports Upbeat Pneumonia Drug Test ResultsTSX:FRXForest Laboratories Inc.
06/10/20099:54AMDow Jones NewsPHARMA MARKET: Wyeth Stands By Pristiq After Slow StartTSX:FRXForest Laboratories Inc.
05/22/20093:34PMDow Jones NewsDrug Makers To Pay $89 Million To Settle Alabama Medicaid Price SuitsTSX:FRXForest Laboratories Inc.
05/05/200910:03AMDow Jones News2nd UPDATE:Jubilant Organosys Unit In Pact With AstraZenecaTSX:FRXForest Laboratories Inc.
04/30/20093:01AMDow Jones NewsAlmirall, Forest See New Drug Application For COPD By 2012TSX:FRXForest Laboratories Inc.
04/21/20098:09AMDow Jones NewsForest Labs 4Q Net Drops 46% Amid Marketing Probe Set-AsideTSX:FRXForest Laboratories Inc.
04/03/20096:34PMDow Jones NewsUPDATE: FDA Warns World's Largest Drug Firms Over Internet AdsTSX:FRXForest Laboratories Inc.
04/03/20095:22PMDow Jones NewsFDA Warns World's Largest Drug Firms Over Internet AdsTSX:FRXForest Laboratories Inc.
03/06/20096:21AMDow Jones NewsFDA Wants More Study On Almirall, Forest Labs COPD DrugTSX:FRXForest Laboratories Inc.
02/25/20094:24PMDow Jones NewsUPDATE:DOJ:Forest Labs Engaged In Improper Marketing,KickbacksTSX:FRXForest Laboratories Inc.
 Showing the most relevant articles for your search:LSE:FRX